We work tirelessly towards a world where people live longer, healthier lives from cancers prevented, caught early, or cured.
Investing in cutting-edge research to prevent, detect, and treat ovarian cancer, a deadly and underfunded disease.
Over $15.8 Million
232 Research Grants Funded
Large Applicant Pool
115 applicants each year for the past 5 years
15x Return on Investment
Rivkin-funded scientists receive 15x in new funding from other institutions after Rivkin’s initial investment
Our current funding rate is 8%, meaning we are leaving important science on the table. We want to see funding rates increase to 15% in two years.
Educating and empowering individuals to prevent and detect ovarian and breast cancer as early as possible.
Educated over 31k people
at 850 educational workshops in 6 states
40% of programming
Low Income, Minority, LGBTQ+, Ashkenazi Jewish Heritage
Represented at all Pac-12 schools
95% of attendants
People assessed their risk for ovarian and breast cancer on Rivkin website in 2020. That’s up from 792 in 2018.
Fostering an ever-growing community of survivors, patients, researchers, clinicians, and advocates.
32% increase in attendees
(over 250 attendees)
1,000 SummeRun Participants
at the 2021 SummeRun & Walk
in the education programs, up from 25 in 2016.
For more details and information on the Rivkin Center’s work in 2021: